IPO7 Antikörper (C-Term)
-
- Target Alle IPO7 Antikörper anzeigen
- IPO7 (Importin 7 (IPO7))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IPO7 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Flow Cytometry (FACS)
- Verwendungszweck
- RANBP7 / Importin 7
- Sequenz
- SSFNFGGPAP GMN
- Homologie
- Human, Mouse, Rat, Dog, Cow
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-SSFNFGGPAPGMN, from the C Terminus of the protein sequence according to NP_006382.1.
- Isotyp
- IgG
- Top Product
- Discover our top product IPO7 Primärantikörper
-
-
- Applikationshinweise
-
Peptide ELISA: antibody detection limit dilution 1:4000.
- Kommentare
-
Flow Cytometry: Flow cytometric analysis of HeLa cells. Recommended concentration: 10ug/ml.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Nucleocytoplasmic shuttling of the zinc finger protein EZI Is mediated by importin-7-dependent nuclear import and CRM1-independent export mechanisms." in: The Journal of biological chemistry, Vol. 282, Issue 44, pp. 32327-37, (2007) (PubMed).
: "
-
Nucleocytoplasmic shuttling of the zinc finger protein EZI Is mediated by importin-7-dependent nuclear import and CRM1-independent export mechanisms." in: The Journal of biological chemistry, Vol. 282, Issue 44, pp. 32327-37, (2007) (PubMed).
-
- Target
- IPO7 (Importin 7 (IPO7))
- Andere Bezeichnung
- IPO7 (IPO7 Produkte)
- Synonyme
- fb33d09 antikoerper, wu:fb33d09 antikoerper, zgc:66425 antikoerper, zgc:76878 antikoerper, imp7 antikoerper, ranbp7 antikoerper, Imp7 antikoerper, RANBP7 antikoerper, A330055O14Rik antikoerper, C330016G14 antikoerper, Ranbp7 antikoerper, importin 7 antikoerper, importin 7 S homeolog antikoerper, importin-7 antikoerper, karyopherin antikoerper, ipo7 antikoerper, ipo7.S antikoerper, IPO7 antikoerper, CpipJ_CPIJ002096 antikoerper, PTRG_08544 antikoerper, SJAG_03693 antikoerper, NAEGRDRAFT_71372 antikoerper, VDBG_01971 antikoerper, MGYG_08162 antikoerper, Tsp_01943 antikoerper, Tsp_01946 antikoerper, Ipo7 antikoerper
- Hintergrund
- IPO7, importin 7, RANBP7, FLJ14581, MGC138673, RAN binding protein 7, RAN-binding protein 7
- Gen-ID
- 10527
- NCBI Accession
- NP_006382
- Pathways
- Protein targeting to Nucleus
-